Clopidogrel is prescribed to help prevent heart attack or stroke. It's a generic medication and is available as the brand-name drug Plavix. It comes as an oral tablet. The cost of clopidogrel can vary ...

News of the expanded indication comes during a showdown between the marketer/manufacturer of the drug, Bristol-Myers Squibb (BMS)/Sanofi-Aventis, and Canadian drug company Apotex, which started ...

BARCELONA (Reuters) - AstraZeneca's new pill Brilinta for preventing heart attacks works better than Plavix, the world's second biggest selling drug, without increasing the amount of life-threatening ...

WASHINGTON - Federal health officials are investigating whether the blood thinner Plavix - the world's second-best-selling drug and used by millions to reduce the risk of heart attack and stroke - may ...

The US Food and Drug Administration (FDA) announced it has approved eleven generic versions of Bristol-Myers Squibb and Sanofi's blockbuster blood-thinner Plavix (clopidogrel bisulfate), marking the ...

NEW YORK, Oct 23 (Reuters) - A small study presented on Monday suggests Eli Lilly and Co.'s experimental blood clot preventer, prasugrel, works faster and could be more effective than the commonly ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

HONOLULU (AP) — Pharmaceutical companies have agreed to pay Hawaii $700 million to settle its lawsuit over the efficacy and safety of the blood thinner Plavix, the state attorney general’s office ...

This year, Peter R. Dolan, the CEO of Bristol-Myers Squibb, was faced with the threat of generic competition for Plavix, an anti-clotting drug with $3.2 billion in annual U.S. sales. In responding to ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. HONOLULU (AP) — Pharmaceutical companies ...